title: Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-making.
abstract: Clinical guidelines advocate stroke prevention therapy in atrial fibrillation (AF) patients, specifically anticoagulation. However, the decision to initiate treatment is based on the risk (bleeding) versus benefit (prevention of stroke) of therapy, which is often difficult to assess. This review identifies available risk assessment tools to facilitate the safe and optimal use of antithrombotic therapy for stroke prevention in AF. Using key databases and online clinical resources to search the literature (1992-2012), 19 tools have been identified and published to date: 11 addressing stroke risk, 7 addressing bleeding risk and 1 integrating both risk assessments. The stroke risk assessment tools (e.g. CHADS2, CHA2DS2-VASc) share common risk factors: age, hypertension, previous cerebrovascular attack. The bleeding risk assessment tools (e.g. HEMORR2HAGES, HAS-BLED) share common risk factors: age, previous bleeding, renal and liver impairment. In terms of their development, six of the stroke risk assessment tools have been derived from clinical studies, whilst five are based on refinement of existing tools or expert consensus. Many have been evaluated by prospective application to data from real patient cohorts. Bleeding risk assessment tools have been derived from trials, or generated from patient data and then validated via further studies. One identified tool (i.e. Computerised Antithrombotic Risk Assessment Tool [CARAT]) integrates both stroke and bleeding, and specifically considers other key factors in decision-making regarding antithrombotic therapy, particularly those increasing the risk of medication misadventure with treatment (e.g. function, drug interactions, medication adherence). This highlights that whilst separate tools are available to assess stroke and bleeding risk, they do not estimate the relative risk versus benefit of treatment in an individual patient nor consider key medication safety aspects. More effort is needed to synthesize these separate risk assessments and integrate key medication safety issues, particularly since the introduction of new anticoagulants into practice.
authors.affiliation: Graduate School of Health: School of Pharmacy, University of Technology Sydney (UTS), CB01.13, PO Box 123, Broadway, NSW 2007, Australia.
authors.forename: Yishen
authors.initials: Y
authors.lastname: Wang
authors.affiliation: Graduate School of Health: School of Pharmacy, The University of Technology, Sydney, NSW, Australia.
authors.forename: Beata
authors.initials: B
authors.lastname: Bajorek
keywords: atrial fibrillation; bleeding; decision making; risk assessment; risk versus benefit; stroke; stroke prevention
references.citation: Am J Med. 1998 Aug;105(2):91-9
references.pmid: 9727814
references.citation: J Am Coll Cardiol. 2011 Jan 11;57(2):173-80
references.pmid: 21111555
references.citation: Stroke. 2010 Dec;41(12):2731-8
references.pmid: 20966417
references.citation: Chest. 2006 Nov;130(5):1390-6
references.pmid: 17099015
references.citation: J Am Coll Cardiol. 2011 Jul 19;58(4):395-401
references.pmid: 21757117
references.citation: Stroke. 1995 May;26(5):801-6
references.pmid: 7740570
references.citation: Eur Heart J. 2008 May;29(9):1181-9
references.pmid: 18397874
references.citation: Drugs Aging. 2010 Jan 1;27(1):39-50
references.pmid: 20030431
references.citation: J Am Coll Cardiol. 2011 Mar 15;57(11):e101-98
references.pmid: 21392637
references.citation: Am Heart J. 2006 Mar;151(3):713-9
references.pmid: 16504638
references.citation: Expert Opin Drug Saf. 2006 May;5(3):417-31
references.pmid: 16610970
references.citation: Pharm Pract (Granada). 2009 Apr;7(2):113-23
references.pmid: 25152787
references.citation: Lancet. 1989 Jan 28;1(8631):175-9
references.pmid: 2563096
references.citation: J Am Coll Cardiol. 2013 Jan 22;61(3):386-7
references.pmid: 23246385
references.citation: Circulation. 2012 Jan 3;125(1):e2-e220
references.pmid: 22179539
references.citation: JAMA. 2002 Nov 20;288(19):2441-8
references.pmid: 12435257
references.citation: Lancet. 1993 Nov 20;342(8882):1255-62
references.pmid: 7901582
references.citation: Curr Hematol Rep. 2002 Sep;1(1):41-9
references.pmid: 12901124
references.citation: Ann Intern Med. 2007 Jun 19;146(12):857-67
references.pmid: 17577005
references.citation: Am J Med. 1989 Aug;87(2):144-52
references.pmid: 2787958
references.citation: Thromb Haemost. 2008 Jul;100(1):16-7
references.pmid: 18612532
references.citation: Ther Adv Drug Saf. 2011 Apr;2(2):45-58
references.pmid: 25083201
references.citation: JAMA. 1994 Mar 16;271(11):840-4
references.pmid: 8114238
references.citation: Arch Intern Med. 1999 Mar 8;159(5):457-60
references.pmid: 10074953
references.citation: Chest. 2010 Nov;138(5):1093-100
references.pmid: 20299623
references.citation: J Am Coll Cardiol. 1991 Aug;18(2):349-55
references.pmid: 1856403
references.citation: Am Heart J. 2008 Jul;156(1):57-64
references.pmid: 18585497
references.citation: JAMA. 2003 Nov 26;290(20):2685-92
references.pmid: 14645310
references.citation: N Engl J Med. 1992 Nov 12;327(20):1406-12
references.pmid: 1406859
references.citation: Ann Intern Med. 1999 Dec 21;131(12):927-34
references.pmid: 10610643
references.citation: Med J Aust. 2007 Feb 19;186(4):175-80
references.pmid: 17309417
references.citation: N Engl J Med. 1991 Jul 11;325(2):129-32
references.pmid: 2052049
references.citation: N Engl J Med. 1990 Nov 29;323(22):1505-11
references.pmid: 2233931
references.citation: J Thromb Haemost. 2011 Jan;9(1):39-48
references.pmid: 21029359
references.citation: Circulation. 2011 Mar 1;123(8):933-44
references.pmid: 21262990
references.citation: N Engl J Med. 2011 Sep 15;365(11):981-92
references.pmid: 21870978
references.citation: Heart Rhythm. 2011 Jan;8(1):157-76
references.pmid: 21182985
references.citation: BMJ. 2011 Jan 31;342:d124
references.pmid: 21282258
references.citation: Arch Intern Med. 1994 Jul 11;154(13):1449-57
references.pmid: 8018000
references.citation: N Engl J Med. 2003 Aug 14;349(7):631-9
references.pmid: 12917299
references.citation: Can J Cardiol. 2012 Mar-Apr;28(2):125-36
references.pmid: 22433576
references.citation: Stroke. 2007 Sep;38(9):2459-63
references.pmid: 17673721
references.citation: Circ Arrhythm Electrophysiol. 2012 Oct;5(5):941-8
references.pmid: 22923275
references.citation: Europace. 2012 Oct;14(10):1385-413
references.pmid: 22923145
references.citation: Drugs Aging. 2010 Oct 1;27(10):807-13
references.pmid: 20883061
references.citation: Chest. 2012 Feb;141(2 Suppl):e531S-e575S
references.pmid: 22315271
references.citation: J Am Geriatr Soc. 2005 Nov;53(11):1912-20
references.pmid: 16274372
references.citation: N Engl J Med. 1997 Sep 4;337(10):657-62
references.pmid: 9280815
references.citation: J Am Coll Cardiol. 2012 Aug 28;60(9):861-7
references.pmid: 22858389
references.citation: Stroke. 2006 Sep;37(9):2294-300
references.pmid: 16888271
references.citation: Stroke. 1991 Aug;22(8):983-8
references.pmid: 1866765
references.citation: Chest. 2010 Feb;137(2):263-72
references.pmid: 19762550
references.citation: Australas J Ageing. 2012 Jun;31(2):102-9
references.pmid: 22676169
references.citation: Eur Heart J. 2007 Nov;28(22):2803-17
references.pmid: 17897924
references.citation: N Engl J Med. 2011 Sep 8;365(10):883-91
references.pmid: 21830957
references.citation: Circulation. 2011 Feb 1;123(4):e18-e209
references.pmid: 21160056
references.citation: J Stroke Cerebrovasc Dis. 1995;5(3):147-57
references.pmid: 26486811
references.citation: N Engl J Med. 2009 Sep 17;361(12):1139-51
references.pmid: 19717844
references.citation: Thromb Haemost. 2008 Jul;100(1):26-31
references.pmid: 18612534
references.citation: Stroke. 1999 Jun;30(6):1223-9
references.pmid: 10356104
references.citation: JAMA. 2001 Jun 13;285(22):2864-70
references.pmid: 11401607
references.citation: JAMA. 2003 Aug 27;290(8):1049-56
references.pmid: 12941677
references.citation: Chest. 2013 Jan;143(1):179-184
references.pmid: 22722228
references.citation: Arch Intern Med. 1998 Jun 22;158(12):1316-20
references.pmid: 9645825